Privia Health Group, Inc. (NASDAQ:PRVA) Holdings Raised by Riverbridge Partners LLC

Riverbridge Partners LLC increased its position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 19.7% during the 4th quarter, HoldingsChannel.com reports. The firm owned 5,824,458 shares of the company’s stock after purchasing an additional 958,418 shares during the period. Privia Health Group accounts for 1.6% of Riverbridge Partners LLC’s investment portfolio, making the stock its 22nd biggest position. Riverbridge Partners LLC’s holdings in Privia Health Group were worth $113,868,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Nisa Investment Advisors LLC grew its stake in Privia Health Group by 185.7% during the 4th quarter. Nisa Investment Advisors LLC now owns 4,999 shares of the company’s stock worth $98,000 after buying an additional 3,249 shares during the last quarter. Financial Management Professionals Inc. bought a new stake in Privia Health Group in the 4th quarter valued at about $51,000. Park Avenue Securities LLC increased its stake in shares of Privia Health Group by 3.8% in the fourth quarter. Park Avenue Securities LLC now owns 14,697 shares of the company’s stock valued at $287,000 after purchasing an additional 532 shares during the period. Nordea Investment Management AB boosted its position in shares of Privia Health Group by 33.1% during the fourth quarter. Nordea Investment Management AB now owns 349,773 shares of the company’s stock worth $6,953,000 after buying an additional 86,910 shares during the period. Finally, JPMorgan Chase & Co. increased its position in Privia Health Group by 8.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 188,384 shares of the company’s stock valued at $3,430,000 after acquiring an additional 14,641 shares during the period. Institutional investors and hedge funds own 94.48% of the company’s stock.

Privia Health Group Stock Performance

Shares of PRVA stock opened at $22.68 on Thursday. The company has a market capitalization of $2.72 billion, a price-to-earnings ratio of 226.82, a PEG ratio of 3.07 and a beta of 0.85. The stock’s 50 day simple moving average is $21.02 and its 200 day simple moving average is $19.72. Privia Health Group, Inc. has a twelve month low of $15.92 and a twelve month high of $23.49.

Wall Street Analysts Forecast Growth

PRVA has been the topic of a number of recent analyst reports. Needham & Company LLC began coverage on shares of Privia Health Group in a research note on Friday, January 10th. They set a “buy” rating and a $25.00 price objective on the stock. Stephens restated an “overweight” rating and set a $26.00 price target on shares of Privia Health Group in a research report on Thursday, January 2nd. KeyCorp started coverage on shares of Privia Health Group in a report on Friday, October 11th. They issued an “overweight” rating and a $23.00 price objective for the company. Truist Financial upped their target price on Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. Finally, Barclays increased their price target on Privia Health Group from $19.00 to $21.00 and gave the company an “equal weight” rating in a research note on Friday, November 8th. Two research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $24.88.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.